Brief: Arca Biopharma Establishes Special Committee Of The Board Of Directors
18/04/2022 21:50
April 18 (Reuters) - ARCA Biopharma Inc ABIO.O :
* ARCA BIOPHARMA ESTABLISHES SPECIAL COMMITTEE OF THE BOARD
OF
DIRECTORS
* ARCA BIOPHARMA INC - BOARD OF DIRECTORS HAS ESTABLISHED A
SPECIAL COMMITTEE TO EVALUATE STRATEGIC OPTIONS FOR MAXIMIZING
STOCKHOLDER VALUE
* ARCA BIOPHARMA INC - BELIEVES THERE ARE MULTIPLE POTENTIAL
OPPORTUNITIES TO ENHANCE VALUE FOR ARCA STOCKHOLDERS
* ARCA BIOPHARMA INC - SPECIAL COMMITTEE INCLUDES ARCA BOARD
CHAIRMAN ROBERT E. CONWAY
Source text for Eikon: ID:nGNX5GVW5Q
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary